Wenzhou Kangning Hospital Co., Ltd.

Informe Stock SEHK:2120

Capitalización de mercado: HK$851.9m

Wenzhou Kangning Hospital Dirección

Dirección controles de criterios 3/4

Wenzhou Kangning Hospital's El consejero delegado es Lianyue Wang , nombrado en Sep 2011, tiene un mandato de 12.25 años. la remuneración anual total es CN¥683.00K , compuesta por 75.5% salario y 24.5% primas, incluidas acciones y opciones de la empresa. posee directamente 4.95% de las acciones de la empresa, por valor de HK$49.14M . La antigüedad media del equipo directivo y del consejo de administración es de 1.9 años y 2.3 años respectivamente.

Información clave

Lianyue Wang

Chief Executive Officer (CEO)

CN¥683.0k

Compensación total

Porcentaje del salario del CEO75.5%
Permanencia del CEO12.6yrs
Participación del CEO5.0%
Permanencia media de la dirección2.3yrs
Promedio de permanencia en la Junta Directiva2.7yrs

Actualizaciones recientes de la dirección

Recent updates

Estimating The Fair Value Of Wenzhou Kangning Hospital Co., Ltd. (HKG:2120)

Feb 28
Estimating The Fair Value Of Wenzhou Kangning Hospital Co., Ltd. (HKG:2120)

Investors Continue Waiting On Sidelines For Wenzhou Kangning Hospital Co., Ltd. (HKG:2120)

Jan 19
Investors Continue Waiting On Sidelines For Wenzhou Kangning Hospital Co., Ltd. (HKG:2120)

Wenzhou Kangning Hospital (HKG:2120) Has A Somewhat Strained Balance Sheet

Nov 23
Wenzhou Kangning Hospital (HKG:2120) Has A Somewhat Strained Balance Sheet

Wenzhou Kangning Hospital (HKG:2120) Could Be Struggling To Allocate Capital

Jun 16
Wenzhou Kangning Hospital (HKG:2120) Could Be Struggling To Allocate Capital

Returns Are Gaining Momentum At Wenzhou Kangning Hospital (HKG:2120)

Mar 23
Returns Are Gaining Momentum At Wenzhou Kangning Hospital (HKG:2120)

Is Wenzhou Kangning Hospital (HKG:2120) Using Too Much Debt?

Dec 06
Is Wenzhou Kangning Hospital (HKG:2120) Using Too Much Debt?

Returns On Capital Are Showing Encouraging Signs At Wenzhou Kangning Hospital (HKG:2120)

Aug 11
Returns On Capital Are Showing Encouraging Signs At Wenzhou Kangning Hospital (HKG:2120)

Calculating The Fair Value Of Wenzhou Kangning Hospital Co., Ltd. (HKG:2120)

Jul 09
Calculating The Fair Value Of Wenzhou Kangning Hospital Co., Ltd. (HKG:2120)

Wenzhou Kangning Hospital (HKG:2120) Is Experiencing Growth In Returns On Capital

May 12
Wenzhou Kangning Hospital (HKG:2120) Is Experiencing Growth In Returns On Capital

Wenzhou Kangning Hospital (HKG:2120) Has A Pretty Healthy Balance Sheet

Apr 10
Wenzhou Kangning Hospital (HKG:2120) Has A Pretty Healthy Balance Sheet

Wenzhou Kangning Hospital Co., Ltd.'s (HKG:2120) Stock Has Shown Weakness Lately But Financial Prospects Look Decent: Is The Market Wrong?

Feb 25
Wenzhou Kangning Hospital Co., Ltd.'s (HKG:2120) Stock Has Shown Weakness Lately But Financial Prospects Look Decent: Is The Market Wrong?

Will Wenzhou Kangning Hospital (HKG:2120) Multiply In Value Going Forward?

Jan 17
Will Wenzhou Kangning Hospital (HKG:2120) Multiply In Value Going Forward?

Should You Use Wenzhou Kangning Hospital's (HKG:2120) Statutory Earnings To Analyse It?

Dec 23
Should You Use Wenzhou Kangning Hospital's (HKG:2120) Statutory Earnings To Analyse It?

If You Had Bought Wenzhou Kangning Hospital's (HKG:2120) Shares Five Years Ago You Would Be Down 42%

Dec 10
If You Had Bought Wenzhou Kangning Hospital's (HKG:2120) Shares Five Years Ago You Would Be Down 42%

Can Mixed Fundamentals Have A Negative Impact on Wenzhou Kangning Hospital Co., Ltd. (HKG:2120) Current Share Price Momentum?

Nov 27
Can Mixed Fundamentals Have A Negative Impact on Wenzhou Kangning Hospital Co., Ltd. (HKG:2120) Current Share Price Momentum?

Análisis de compensación del CEO

¿Cómo ha cambiado la remuneración de Lianyue Wang en comparación con los beneficios de Wenzhou Kangning Hospital?
FechaCompensación totalSalarioIngresos de la empresa
Dec 31 2023n/an/a

CN¥86m

Sep 30 2023n/an/a

CN¥33m

Jun 30 2023n/an/a

-CN¥19m

Mar 31 2023n/an/a

-CN¥22m

Dec 31 2022CN¥683kCN¥516k

-CN¥24m

Sep 30 2022n/an/a

CN¥12m

Jun 30 2022n/an/a

CN¥48m

Mar 31 2022n/an/a

CN¥46m

Dec 31 2021CN¥489kCN¥397k

CN¥44m

Sep 30 2021n/an/a

CN¥45m

Jun 30 2021n/an/a

CN¥54m

Mar 31 2021n/an/a

CN¥55m

Dec 31 2020CN¥483kCN¥326k

CN¥56m

Sep 30 2020n/an/a

CN¥49m

Jun 30 2020n/an/a

CN¥42m

Mar 31 2020n/an/a

CN¥49m

Dec 31 2019CN¥438kCN¥325k

CN¥57m

Sep 30 2019n/an/a

CN¥74m

Jun 30 2019n/an/a

CN¥91m

Mar 31 2019n/an/a

CN¥86m

Dec 31 2018CN¥455kCN¥324k

CN¥81m

Sep 30 2018n/an/a

CN¥73m

Jun 30 2018n/an/a

CN¥65m

Mar 31 2018n/an/a

CN¥57m

Dec 31 2017CN¥449kCN¥324k

CN¥49m

Compensación vs. Mercado: Lianyue($USD95.22K) está por debajo de la media de empresas de tamaño similar en el mercado Hong Kong ($USD232.89K).

Compensación vs. Ingresos: La compensación de Lianyue ha sido consistente con los resultados de la empresa en el último año.


CEO

Lianyue Wang (54 yo)

12.6yrs

Permanencia

CN¥683,000

Compensación

Ms. Lianyue Wang serves as General Manager at Wenzhou Kangning Hospital Co., Ltd. Since September 2011, and has been its Executive Director since September 22, 2014 were she is primarily responsible for th...


Equipo directivo

NombrePosiciónPermanenciaCompensaciónPropiedad
Weili Guan
Executive Chairman9.6yrsCN¥566.68k24.6%
CN¥ 209.6m
Lianyue Wang
GM & Executive Director12.6yrsCN¥683.00k4.95%
CN¥ 42.2m
Jin Hui
Chief Financial Officer2.3yrssin datossin datos
Ning Xu
Chairman of Supervisory Committee1.8yrssin datossin datos
Jian Wang
Vice GM9.8yrssin datos0.19%
CN¥ 1.6m
Wai Chiu Wong
Joint Company Secretary1.8yrssin datossin datos

2.3yrs

Permanencia media

52yo

Promedio de edad

Equipo directivo experimentado: 2120El equipo directivo de la empresa se considera experimentado (2 años de antigüedad media).


Miembros de la Junta

NombrePosiciónPermanenciaCompensaciónPropiedad
Weili Guan
Executive Chairman9.6yrsCN¥566.68k24.6%
CN¥ 209.6m
Lianyue Wang
GM & Executive Director9.6yrsCN¥683.00k4.95%
CN¥ 42.2m
Ning Xu
Chairman of Supervisory Committee2.2yrssin datossin datos
Jian Wang
Vice GMless than a yearsin datos0.19%
CN¥ 1.6m
Tiefan Xie
Employee Representative Supervisor9.6yrsCN¥38.00ksin datos
Changhao Li
Non-Executive Director2.5yrssin datossin datos
Chengliang Qian
Independent Supervisor6.8yrssin datossin datos
Yongjiu Xu
Shareholder Representative Supervisor2.5yrssin datossin datos
Wentang Zhong
Independent Non Executive Director3.8yrsCN¥70.00ksin datos
Hao Qin
Non-Executive Director2.8yrssin datossin datos
Ling Jin
Independent Non Executive Directorless than a yearsin datossin datos
Sai Chan
Independent Non-Executive Directorless than a yearsin datossin datos

2.7yrs

Permanencia media

45yo

Promedio de edad

Junta con experiencia: 2120no se consideran experimentados ( 2.3 años de permanencia media), lo que sugiere un nuevo consejo.